Provided by Tiger Trade Technology Pte. Ltd.

Insulet

148.16
+1.290.88%
Post-market: 148.160.00000.00%19:55 EDT
Volume:903.61K
Turnover:133.95M
Market Cap:10.26B
PE:27.97
High:150.20
Open:146.87
Low:145.04
Close:146.87
52wk High:354.88
52wk Low:126.40
Shares:69.26M
Float Shares:69.07M
Volume Ratio:0.66
T/O Rate:1.31%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.30
EPS(LYR):3.48
ROE:26.02%
ROA:9.71%
PB:7.22
PE(LYR):42.59

Loading ...

Shopify Stock Leads 3 US Large Cap Picks For AI Driven Growth

Simply Wall St.
·
Jul 13

Insulet Corp. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 11

Stifel Adjusts Price Target on Insulet to $225 From $250

MT Newswires Live
·
Jul 10

Insulet price target lowered to $225 from $250 at Stifel

TIPRANKS
·
Jul 10

Insulet Corp. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Jul 09

Insulet Corporation Faces Federal Securities Lawsuit Over Alleged Manufacturing Defects in Omnipod Products

TIPRANKS
·
Jul 09

Insulet is Maintained at Neutral by Citigroup

Dow Jones
·
Jul 08

Citigroup Adjusts Insulet Price Target to $172 From $165

MT Newswires Live
·
Jul 08

Insulet price target raised to $172 from $165 at Citi

TIPRANKS
·
Jul 08

Citi Sticks to Their Hold Rating for Insulet (PODD)

TIPRANKS
·
Jul 08

Insulet Corp. Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
Jul 07

Dexcom Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 07

Insulet is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
Jul 07

Evercore ISI Adjusts Price Target on Insulet to $180 From $200

MT Newswires Live
·
Jul 06

Insulet Corp. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 03

Insulet Files Form 3 Disclosing Jonathan Jay Mazelsky as Director Beneficial Owner

Reuters
·
Jul 03

Insulet Recalls Omnipod Pods After Insulin-Delivery Failure Risk Identified, FDA Says

MT Newswires Live
·
Jul 03

FDA says Insulet recalled certain Omnipod Pods

TIPRANKS
·
Jul 03

US FDA Classifies Insulet Omnipod Pods Recall as Class I Due to Serious Injury Risk

Reuters
·
Jul 03

US FDA - Insulet Reports 24 Serious Injuries, no Deaths from Omnipod Pods Issue as of May 20

THOMSON REUTERS
·
Jul 03